IRIS
BATTAGLINI, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.734
EU - Europa 3.586
AS - Asia 522
Continente sconosciuto - Info sul continente non disponibili 6
AF - Africa 5
OC - Oceania 4
SA - Sud America 4
Totale 8.861
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.721
GB - Regno Unito 1.391
IE - Irlanda 629
CN - Cina 380
UA - Ucraina 332
SE - Svezia 321
IT - Italia 273
FR - Francia 208
DE - Germania 182
FI - Finlandia 88
SG - Singapore 40
ES - Italia 38
VN - Vietnam 38
RU - Federazione Russa 33
BE - Belgio 19
TR - Turchia 19
MK - Macedonia 13
CA - Canada 11
PH - Filippine 10
HK - Hong Kong 9
CZ - Repubblica Ceca 8
IR - Iran 8
NL - Olanda 8
RO - Romania 7
CH - Svizzera 6
EU - Europa 6
GR - Grecia 5
JP - Giappone 5
HU - Ungheria 4
IN - India 4
RS - Serbia 4
AL - Albania 3
AU - Australia 3
MA - Marocco 3
MD - Moldavia 3
EG - Egitto 2
IL - Israele 2
KZ - Kazakistan 2
LT - Lituania 2
MX - Messico 2
PL - Polonia 2
AR - Argentina 1
AT - Austria 1
BO - Bolivia 1
BR - Brasile 1
BY - Bielorussia 1
CL - Cile 1
DK - Danimarca 1
ID - Indonesia 1
JO - Giordania 1
LU - Lussemburgo 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
PT - Portogallo 1
SA - Arabia Saudita 1
SI - Slovenia 1
TH - Thailandia 1
Totale 8.861
Salva come PNG Salva come JPEG
Città #
Southend 1.292
Fairfield 773
Dublin 624
Houston 558
Woodbridge 393
Chandler 348
Ashburn 343
Seattle 295
Wilmington 295
Jacksonville 273
Cambridge 267
Menlo Park 183
Ann Arbor 159
Princeton 124
Nanjing 106
Siena 97
Beijing 89
San Mateo 45
Boardman 41
Dong Ket 37
Helsinki 35
Málaga 33
Nanchang 31
Shenyang 30
San Diego 27
Moscow 25
Lancaster 19
Norwalk 19
Singapore 19
Brussels 15
Dearborn 14
Florence 14
Jiaxing 14
Kunming 14
Tianjin 14
Hebei 13
New York 13
Düsseldorf 12
Changsha 11
Izmir 11
Fremont 10
Jinan 10
London 10
Pisa 10
Rome 10
San Francisco 10
Los Angeles 9
Milan 9
Hangzhou 7
Ningbo 7
Bonndorf 6
Kilburn 6
Phoenix 6
Central 5
Edinburgh 5
Genoa 5
Munich 5
Shanghai 5
Belgrade 4
Brno 4
Chongqing 4
Hong Kong 4
San Giovanni Valdarno 4
Tappahannock 4
Timisoara 4
Toronto 4
Bari 3
Bern 3
Bologna 3
Chisinau 3
General Trias 3
Groningen 3
Gyomro 3
Haikou 3
Hefei 3
Hounslow 3
Melbourne 3
Padova 3
Radda in Chianti 3
Redwood City 3
Ruvo Di Puglia 3
Sacramento 3
Saint Petersburg 3
Skopje 3
Tokyo 3
Torino 3
Turin 3
Zhengzhou 3
Boston 2
Cascina 2
Castellina in Chianti 2
Changchun 2
Chicago 2
Colle di Val d'Elsa 2
Fabriano 2
Falkenstein 2
Falls Church 2
Frankfurt am Main 2
Fuzhou 2
General Santos 2
Totale 6.982
Salva come PNG Salva come JPEG
Nome #
Imaging distribution and frequency of cortical lesions in patients with multiple sclerosis 390
The role of dentate nuclei in human oculomotor control: Insights from cerebrotendinous xanthomatosis 215
Optimizing parameter choice for FSL-Brain Extraction Tool (BET) on 3D T1 images in multiple sclerosis 184
null 182
Voxel-wise assessment of progression of regional brain atrophy in relapsing-remitting multiple sclerosis 179
Long-term assessment of no evidence of disease activity in relapsing-remitting MS 171
SIENA-XL for improving the assessment of gray and white matter volume changes on brain MRI 171
The spectrum of magnetic resonance findings in cerebrotendinous xanthomatosis: redefinition and evidence of new markers of disease progression 169
Reduced brain atrophy rates are associated with lower risk of disability progression in patients with relapsing multiple sclerosis treated with cladribine tablets. 169
Gray matter atrophy cannot be fully explained by white matter damage in patients with MS 164
Cortical damage in brains of patients with adult-form of myotonic dystrophy type 1 and no or minimal MRI abnormalities 164
Establishing pathological cut-offs of brain atrophy rates in multiple sclerosis 162
Progression of regional grey matter atrophy in multiple sclerosis 160
Relevance of brain lesion location to cognition in relapsing multiple sclerosis 160
Prognostic biomarkers of IFNb therapy in multiple sclerosis patients 158
Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypes 157
Evidence of diffuse damage in frontal and occipital cortex in the brain of patients with post-traumatic stress disorder 157
Twelve-year monitoring of a patient with megalencephalic leukoencephalopathy with subcortical cysts 156
Structural and metabolic damage in brains of patients with SPG11-related spastic paraplegia as detected by quantitative MRI 154
Cortical lesions in radiologically isolated syndrome. 152
[(11)C]PBR28 or [(18)F]PBR111 detect white matter inflammatory heterogeneity in multiple sclerosis 148
Early structural changes in individuals at risk of familial Alzheimer's disease. A volumetry and magnetization transfer MR imaging study 147
Clinical relevance of brain volume changes in patients with cerebrotendinous xanthomatosis 147
Topiramate effects on plasma serotonin levels in children with epilepsy 146
Brain metabolic changes suggestive of axonal damage in radiologically isolated syndrome 142
Voxel-based assessment of differences in damage and distribution of white matter lesions between patients with primary progressive and relapsing-remitting multiple sclerosis. 141
Pronounced structural and functional damage in early adult pediatric-onset multiple sclerosis with no or minimal clinical disability 141
Automated identification of brain new lesions in multiple sclerosis using subtraction images 140
Urgent challenges in quantification and interpretation of brain grey matter atrophy in individual MS patients using MRI 136
A semiautomatic method for multiple sclerosis lesion segmentation on Dual-Echo MR imaging: Application in a multicenter context 135
Association of neocortical volume changes with cognitive deterioration in relapsing-remitting multiple sclerosis 133
Magnetization Transfer Imaging Demonstrates a Distributed Pattern of Microstructural Changes of the Cerebral Cortex in Amyotrophic Lateral Sclerosis 130
Brain atrophy assessment in multiple sclerosis: importance and limitations 129
Cognitive assessment and quantitative magnetic resonance metrics can help to identify benign multiple sclerosis. 128
Deep gray matter volume loss drives disability worsening in multiple sclerosis 128
T2 lesion location really matters: a 10 year follow-up study in primary progressive multiple sclerosis 128
Pronounced focal and diffuse brain damage predicts short-term disease evolution in patients with clinically isolated syndrome suggestive of multiple sclerosis 127
Diffuse structural and metabolic brain changes in Fabry disease 123
Brain damage as detected by magnetization transfer imaging is less pronounced in benign than in early relapsing multiple sclerosis 123
Acute metabolic brain changes following traumatic brain injury and their relevance to clinical severity and outcome. 121
Cortical functional reorganisation and its relationship with brain structural damage in patients with benign multiple sclerosis 121
Improving the characterization of radiologically isolated syndrome suggestive of multiple sclerosis. 118
Neuropsychological and MRI measures predict short-term evolution in benign multiple sclerosis. 117
Location of brain lesions predicts conversion of clinically isolated syndromes to multiple sclerosis 116
Response to the letter “Progression of gray matter atrophy and its association with white matter lesions in relapsing–remitting multiple sclerosis” by Bendfeldt et al. 116
Modelling the distribution of cortical lesions in multiple sclerosis 116
Measuring Brain Atrophy in Multiple Sclerosis 114
Lifespan normative data on rates of brain volume changes 113
Evaluating and reducing the impact of white matter lesions on brain volume measurements 109
The dilemma of benign multiple sclerosis: Can we predict the risk of losing the “benign status”? A 12-year follow-up study 108
null 108
Enhanced brain extraction improves the accuracy of brain atrophy estimation. 104
MRI correlates of disability in african-americans with multiple sclerosis 101
Brain MRI atrophy quantification in MS: From methods to clinical application 97
Magnetization Transfer MR Imaging Demonstrates Degeneration of the Subcortical and Cortical Gray Matter in Huntington Disease 96
Dynamics of pseudo-atrophy in RRMS reveals predominant gray matter compartmentalization 93
Imaging brain damage in first-degree relatives of sporadic and familial multiple sclerosis 92
MAGNIMS consensus recommendations on the use of brain and spinal cord atrophy measures in clinical practice 86
Structural and Metabolic Brain Abnormalities in Preclinical Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarct and Leukoencephalopathy 83
Automated lesion segmentation with BIANCA: Impact of population-level features, classification algorithm and locally adaptive thresholding 81
Short-Term Combination of Glatiramer Acetate with IV Steroid Treatment Preceding Treatment with GA Alone Is Associated with early Suppression of MRI-disease activity in Patients with Relapsing Remitting Multiple Sclerosis 78
Mapping the Progressive Treatment-Related Reduction of Active MRI Lesions in Multiple Sclerosis 77
Mild gray matter atrophy in patients with long-standing multiple sclerosis and favorable clinical course 56
Clinical and MRI measures to identify non-acute MOG-antibody disease in adults 47
MAGNIMS recommendations for harmonization of MRI data in MS multicenter studies 47
Relevance of hypointense brain MRI lesions for long-term worsening of clinical disability in relapsing multiple sclerosis 45
Vitamin D levels in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) 40
Multicenter data harmonization for regional brain atrophy and application in multiple sclerosis 37
Reduction in grey matter atrophy in patients with relapsing multiple sclerosis following treatment with cladribine tablets 29
Evolution from a first clinical demyelinating event to multiple sclerosis in the REFLEX trial: Regional susceptibility in the conversion to multiple sclerosis at disease onset and its amenability to subcutaneous interferon beta-1a 26
Slowly expanding lesions relate to persisting black-holes and clinical outcomes in relapse-onset multiple sclerosis 24
BIANCA (Brain Intensity AbNormality Classification Algorithm): a new tool for automated segmentation of white matter hyperintensities 22
Association of Brain Atrophy with Disease Progression Independent of Relapse Activity in Patients with Relapsing Multiple Sclerosis 21
Resting-state functional MRI in multicenter studies on multiple sclerosis: a report on raw data quality and functional connectivity features from the Italian Neuroimaging Network Initiative 19
Clinically relevant profiles of myelin content changes in patients with multiple sclerosis: A multimodal and multicompartment imaging study 17
The spatio-temporal relationship between white matter lesion volume changes and brain atrophy in clinically isolated syndrome and early multiple sclerosis 13
Quantification of [11C]PIB PET for imaging myelin in the human brain: A test-retest reproducibility study in high-resolution research tomography 13
Brain lesion location and clinical status 20 years after a diagnosis of clinically isolated syndrome suggestive of multiple sclerosis 13
Individual mapping of innate immune cell activation is a candidate marker of patient-specific trajectories of worsening disability in multiple sclerosis 12
Dynamic imaging of individual remyelination profiles in multiple sclerosis 10
Totale 9.002
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.635
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.635
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.125 258 101 202 348 171 185 174 233 159 138 48 108
2020/20211.620 56 165 34 126 59 167 160 264 145 178 139 127
2021/20221.078 80 122 88 92 53 45 69 34 62 92 147 194
2022/20231.355 78 100 156 177 140 225 41 159 150 52 44 33
2023/2024885 45 30 63 34 24 229 345 28 4 13 7 63
2024/202527 27 0 0 0 0 0 0 0 0 0 0 0
Totale 9.002